CONNEQT Launches Reports CardieX Limited

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

CardieX Limited (ASX: CDX), a global health technology company focused on hypertension, cardiovascular disease, and vascular health disorders, today announced CONNEQT™, a new consumer health company that will focus on home vital signs monitors, wearables, and consumer health apps.

Under the CONNEQT brand, CardieX is on track to launch multiple new devices and digital products to the market over the next twelve months.

Upcoming products include the CONNEQT “Pulse” – a dual blood pressure monitor anticipated to be the first consumer vital signs monitor to include central blood pressure and the company’s patented SphygmoCor® technology. In addition, the company is developing a new health wearable, the CONNEQT Band, which includes a full suite of patented health parameters as well as a comprehensive ecosystem of unique health and wellness features focused on heart health.

“Our goal with the development of a new brand for our consumer health products was to create an emotional connection and brand recognition to compete with leaders in the field such as Fitbit, Apple, Google Health, Peloton, Whoop, Garmin, and others,” said Craig Cooper, CEO and Co-founder of CardieX. “We believe that CONNEQT will disrupt health and fitness devices in the same way Beats disrupted Bose, Warby Parker disrupted the eyeglass industry, and Instagram disrupted photo sharing.”

Cooper stated, “We are uniquely positioned to be a strong market entrant into the $US100B health wearables market given our focus on vascular and heart health – the world’s #1 killer.”

Last week CardieX was granted another US patent for blood pressure measurement technology for “Non-Invasive Brachial Blood Pressure Measurement” which will remain in force until 2038. The company also holds over 14 patents in blood pressure and wearable sensor technologies which are being incorporated into their new CONNEQT devices.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles